Results 131 to 140 of about 5,099,009 (221)

Trials in progress: CARMAN - study protocol of a randomized controlled, international, multicenter, open-label phase II trial evaluating early treatment intensification in patients with high-risk mantle cell lymphoma using CAR-T-cell treatment after an abbreviated induction therapy with rituximab and ibrutinib and 6 months ibrutinib maintenance as compared to standard of care induction and maintenance. [PDF]

BMC Cancer
Tilch MK, Schmidt C, Trneny M, Giné E, Hermine O, Ohler A, Herold S, Hoster E, Jiang L, Pott C, Dreyling M, Hess G.   +11 more
europepmc   +1 more source

Glofitamab in Heavily Pretreated Mantle Cell Lymphoma Patients: A Multicenter Real-World Case Series. [PDF]

EJHaem
Rotter N, Raderer M, List A, Haslbauer F, Saini O, Egle A, Magnes T, Leisch M, Kaynak E, Buxhofer-Ausch V, Casadei B, Keil F, Rumpold H, Hess G, Greil R, Zinzani PL, Melchardt T.   +16 more
europepmc   +1 more source

CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma. [PDF]

Am J Clin Pathol
Sethapati VR, Ngo V, Danilov A, Phillips T, Shouse G, Herrera A, Perry AM, Li A, Kwak L, Weisenburger DD, Chan WC, Song JY.   +11 more
europepmc   +1 more source

Clinical Impact of a Germline CD19 Variant on Treatment Outcome After CAR-T Cell Therapy in Relapsed/Refractory Mantle Cell Lymphoma. [PDF]

Cancers (Basel)
Ruckstuhl SA, Seipel K, Shaforostova I, Bertschinger M, Bacher U, Pabst T.   +5 more
europepmc   +1 more source

Bilateral Conjunctival Small Lymphocytic Lymphoma Simulating Inflammatory Ocular Surface Disease: A Case Report. [PDF]

Vision (Basel)
Vivas M, Almeida J, Monteiro C, Ferreira M, Prieto I.   +4 more
europepmc   +1 more source

Tumor Lysis Syndrome Risk in Burkitt Lymphoma Versus Mantle Cell Lymphoma During Alkylating Therapy: A Propensity-Matched TriNetX Comparative Outcome Analysis. [PDF]

Cureus
Homeniuk A, Karthikeyan G, Atrash A.
europepmc   +1 more source

Long-term complete remission following treatment with polatuzumab vedotin, rituximab, and bendamustine in a patient with mantle cell lymphoma relapsing after CAR-T cell therapy: a case report. [PDF]

Ther Adv Med Oncol
Sunder-Plassmann V, Kiesewetter B, Raderer M.   +2 more
europepmc   +1 more source

Cutaneous Involvement by Blastoid Mantle Cell Lymphoma Presenting as Cervical Abscess: A Rare Extranodal Diagnostic Challenge. [PDF]

J Cutan Pathol
Sharma S, Soni A, Rana MK, Kapatia G, Dhankhar A.   +4 more
europepmc   +1 more source

Where next for BTKi-BCL2i combinations in mantle cell lymphoma? [PDF]

Br J Haematol
Eyre TA.
europepmc   +1 more source